Merck Forward P/E

The Forward P/E of Merck & Co Inc (MRK) is 8.87.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

Merck Forward P/E - Peers Comparison

Ticker	Name	Value
PAHC	Phibro Animal Health Corp	14.26
PFE	Pfizer Inc	8.27
INVA	Innoviva Inc	27.62
JNJ	Johnson & Johnson	14.54
LLY	Eli Lilly and Co	35.36
BMY	Bristol-Myers Squibb Co	6.89
BHC.TO	Bausch Health Companies Inc	1.53
ZTS	Zoetis Inc	24.59
AMRX	Amneal Pharmaceuticals Inc	11.45
VTRS	Viatris Inc	4.10
ENDP	Endo International PLC	0.12
GTII.CN	Green Thumb Industries Inc	24.24
CTLT	Catalent Inc	55.81
HZNP	Horizon Therapeutics PLC	25.39
JAZZ	Jazz Pharmaceuticals PLC	21.44
MNKKQ	Mallinckrodt PLC	0.00
PCRX	Pacira Biosciences Inc	8.25
CORT	Corcept Therapeutics Inc	48.04
SUPN	Supernus Pharmaceuticals Inc	18.54